LCM
RVLP

Laurion Capital Management’s RVL Pharmaceuticals plc Ordinary Shares RVLP Stock Holding History

Laurion Capital Management’s Portfolio RVLP Stock Details RVLP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-10,000
Closed -$78K – 1395
2018
Q4 		$78K Buy
+10,000
New +$80K ﹤0.01% 1030

Other funds holding RVLP

GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
ECM
Endurant Capital Management San Mateo, California $17.4M AUM 7.38% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
JAM
JW Asset Management Miami Beach, Florida $244M AUM 71.51% 1-Year Est. Return

Laurion Capital Management's RVLP Position: Q1 2019 in Review

Laurion Capital Management sold out of RVL Pharmaceuticals plc Ordinary Shares (RVLP) in Q1 2019, closing a stake of 10,000 shares — an estimated $78K sold.

Laurion Capital Management first reported a position in RVLP in Q4 2018 and held it in 1 quarter. The position peaked at $78K in Q4 2018. 36 funds tracked by Wall St. Rank hold RVLP as of Q1 2019.

  • Laurion Capital Management reported no remaining RVL Pharmaceuticals plc Ordinary Shares position as of Q1 2019 after selling out during the quarter.
  • Laurion Capital Management sold 10,000 RVL Pharmaceuticals plc Ordinary Shares shares in Q1 2019, an estimated $78K.
  • Laurion Capital Management first reported a position in RVL Pharmaceuticals plc Ordinary Shares in Q4 2018 and held it in 1 quarter.
  • Laurion Capital Management's RVL Pharmaceuticals plc Ordinary Shares position peaked at $78K in Q4 2018.
  • 36 funds tracked by Wall St. Rank held RVL Pharmaceuticals plc Ordinary Shares as of Q1 2019.

Based on Laurion Capital Management's 13F filing for Q1 2019, filed 8 May 2019.